News
12h
Live Science on MSN2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
There is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms.
While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...
The FDA also requested Novavax conduct a phase 4 study in patients aged 50 to 64 years without high-risk conditions for severe COVID-19.
There also was no link between miscarriage risk and the number of vaccinations a woman had gotten, or whether she’d gotten ...
Just 13 percent of children have gotten the latest Covid shot, according to the most recent CDC data. And after Republicans, ...
6d
Green Matters on MSNCOVID-19 Vaccine Deemed Safe Long Term in New Study, Most Common Side Effects RevealedA half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
During an interview in late April with Dr. Phil, Robert F. Kennedy Jr. reiterated his appeal to parents on vaccine safety: ...
The Associated Press on MSN12d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shotA combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results